Dreams: no data
Vivid dreams, nightmares and insomnia are not among the adverse reactions listed in the Wegovy or Zepbound labels.[1][2] We found no study that measured dreams in people on these drugs. Going to bed hungry, nausea and night-time reflux can all disturb sleep, but whether they explain the forum reports is unknown.
Sleep apnea: real data
Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. In two 52-week trials, people started with an average of about 50 breathing pauses or shallow-breathing events an hour (the apnea-hypopnea index). Those on tirzepatide had 25.3 and 29.3 fewer events an hour, against 5.3 and 5.5 fewer on placebo.[2]
When to mention sleep
Loud snoring, choking at night or heavy daytime sleepiness are worth raising whether or not you are on a GLP-1, because sleep apnea is common and treatable.
The short version
Short on the way. A 35-second captioned version of this page is in production for the Fewer Bites channel. It will be embedded here when it is live.
Questions to bring to your prescriber
Print these or screenshot them. They are conversation starters, not a checklist of things to do.
- My sleep has changed since starting: could nausea, reflux or hunger at night be part of it?
- Do I have signs of sleep apnea that are worth testing?
Education, not advice. This page explains what trials, labels and guidelines report. It does not tell anyone to start, change or stop a medicine. Your prescriber knows your history; this page does not.
Sources
- Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, prescribing information, revised 06/2026. label
- Eli Lilly / FDA. Zepbound (tirzepatide) prescribing information, revised 08/2026. label